Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 9/20 | 0.52 |
| ▸ | WNT1 | P04628 | 4/20 | 0.52 |
| ▸ | KDR | P35968 | 3/20 | 0.50 |
| ▸ | KIT | P10721 | 1/20 | 0.50 |
| ▸ | FLT3 | P36888 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.48 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26686055 | 1.00 | DYRK1A (0.52) | DYRK1AWNT1KDRKITFLT3 | |
| SCHEMBL26685950 | 0.99 | DYRK1A (0.51) | DYRK1AWNT1KDRKITFLT3 | |
| SCHEMBL31420125 | 0.99 | DYRK1A (0.51) | DYRK1AWNT1KDRKITFLT3 | |
| SCHEMBL31240358 | 0.84 | ULK1 (0.61) | — | |
| SCHEMBL26685865 | 0.84 | ULK1 (0.61) | — | |
| SCHEMBL26686403 | 0.84 | JAK2 (0.52) | DYRK1AWNT1 | |
| SCHEMBL31420111 | 0.83 | F11 (0.46) | DYRK1AWNT1MAPK1MAP4K4 | |
| SCHEMBL26685887 | 0.83 | F11 (0.46) | DYRK1AWNT1MAPK1MAP4K4 | |
| SCHEMBL26686340 | 0.80 | JAK2 (0.56) | DYRK1AKDRMAPK1MAP4K4 | |
| SCHEMBL31240315 | 0.79 | MAPK1 (0.56) | DYRK1AKDRMAPK1MAP4K4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119562945-A | IKK inhibitors | 癌症研究技术有限公司 | 2025-03-04 | — | — | CN | claimed |
| EP-4705291-A1 | IKK-ALPHA INHIBITORS | Cancer Research Technology Limited (GB) | 2026-03-11 | — | — | EP | disclosed |
| EP-4522597-A1 | IKK INHIBITORS | Cancer Research Technology Limited (GB) | 2025-03-19 | — | — | EP | disclosed |
| CN-119562945-A | IKK inhibitors | 癌症研究技术有限公司 | 2025-03-04 | — | — | CN | disclosed |
| WO-2024228035-A1 | IKK-ALPHA INHIBITORS | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2024-11-07 | — | — | WO | disclosed |
| WO-2023218201-A1 | IKK INHIBITORS | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2023-11-16 | — | — | WO | disclosed |